EquityZen Growth Technology Fund LLC - Series 2129
Raised
$291K
Investors
16
Min Invest
$10,028
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2129 is a Delaware-organized pooled investment vehicle filed by EquityZen Advisors LLC on 2025-09-15, raising $291K from 16 investors under Rule 506(b) and Section 3(c)(1). Minimum investment is $10K. This is part of EquityZen's platform of pre-IPO secondary market SPVs, which has filed for nearly 1,900 related entities.
This pre-IPO vehicle follows the standard EquityZen template: 506(b) private placement combined with 3(c)(1) exemption from Investment Company Act registration, targeting retail-accessible minimums ($10K). The per-investor average of approximately $18K is consistent with EquityZen's democratized access model for late-stage private company exposure.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.